The Saudi Food and Drug Authority (SFDA) has launched a new webpage on its official website dedicated to its membership in the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).
The page features draft guidelines—currently under development— for public consultation from the private sector feedback as well as the adopted guidelines by the SFDA. It also includes a list of the ICH working groups in which the SFDA experts actively participating.
This initiative reflects SFDA’s commitment to advancing the national drug regulatory framework, enhancing stakeholder engagement in following its global initiatives and strengthening the Kingdom’s presence and role in harmonizing with global regulatory practices.
It is worth noting that in June 2024, the SFDA was elected as a member of the ICH Management Committee, becoming the first entity in the Middle East to join this committee. The SFDA had previously joined the Council as a Regulatory Member in June 2021.
){kind=link}